|
Depressive Symptoms
|
0.090 |
Biomarker
|
phenotype |
BEFREE |
Results indicated that participants viewed the treatment as being effective in ameliorating their depressive symptoms and improving their adherence to ART .
|
30652921 |
2019 |
|
Depressive Symptoms
|
0.090 |
GeneticVariation
|
phenotype |
BEFREE |
The prevalence of risky alcohol consumption (AUDIT) and associations with depressive symptoms (PHQ-9), problematic drug use (DUDIT), adherence to ART (CASE Adherence Index), sexual behaviour and demographic characteristics were assessed among both patient groups independently.
|
31664572 |
2019 |
|
Depressive Symptoms
|
0.090 |
Biomarker
|
phenotype |
BEFREE |
ART adherence and depressive symptoms were examined as mediators of the association.
|
30725397 |
2019 |
|
Depressive Symptoms
|
0.090 |
Biomarker
|
phenotype |
BEFREE |
We sought to describe the prevalence of depressive symptoms and outcomes one year after screening among patients receiving ART at a large HIV Clinic in Johannesburg, South Africa.
|
30252844 |
2018 |
|
Depressive Symptoms
|
0.090 |
GeneticVariation
|
phenotype |
BEFREE |
Having 2 years and above duration on ART [AOR = 7, 95% CI (2.2, 22.6)], history of adverse effect [AOR = 6.9, 95% CI (1.4, 32.9)], substance use [AOR = 5.3, 95% CI (1.4, 20.0)], living with parents [AOR = 3.4, 95% CI (1.2, 10.3)], having depression symptom [AOR = 3.3, 95% CI (1.4, 7.5)], <350 cells/mm<sup>3</sup> cluster of differentiation 4 count [AOR = 3.2, 95% CI (1.8, 5.8)] and low dietary diversity [AOR = 2, 95% CI (1.1, 3.7)] were found significant determinants of non-adherence to antiretroviral drug.
|
28331527 |
2017 |
|
Depressive Symptoms
|
0.090 |
GeneticVariation
|
phenotype |
BEFREE |
In analyses adjusted for gender/sexual orientation, ethnicity, age and time since starting ART, factors strongly associated with inaccurate self-report of VL (including "don't know") included socioeconomic disadvantage [prevalence ratio (95% CI) for "not" vs. "always" having enough money for basic needs: 2.4 (1.9, 3.1)], poor English fluency [3.5 (2.4, 5.1) vs. UK born], nondisclosure of HIV status [1.7 (1.3, 2.1)], ART nonadherence [2.1 (1.7, 2.7) for three or more missed doses vs. none in the past 2 weeks] and depressive symptoms (PHQ-9 score ≥ 10) [1.9 (1.6, 2.2)].
|
28004523 |
2017 |
|
Depressive Symptoms
|
0.090 |
Biomarker
|
phenotype |
BEFREE |
However, multivariable negative binomial regression analyses showed no effect of age, HIV status, CD4 levels, viral loads, ART, or opportunistic infections on the risk of depressive symptoms.
|
28231258 |
2017 |
|
Depressive Symptoms
|
0.090 |
GeneticVariation
|
phenotype |
BEFREE |
At 3 months, the CBT-BISC condition showed substantial improvement in BDD-YBOCS (b = -13.6, SE = 2.7, 95% CI [-19.0, -8.3], p < .001; dppc2 = 2.39); MADRS (b = -4.9, SE = 2.8, 95% CI [-10.6, .70], p = .086; dppc2 = .87); ART adherence (b = 8.8, SE = 3.3, 95% CI [2.0, 15.6], p = .01; dppc2 = .94); and GAF (b = 12.3, SE = 3.2, 95% CI [6.1, 18.6], p < .001; dppc2 = 2.91) compared with the ETAU condition.
|
28541068 |
2017 |
|
Depressive Symptoms
|
0.090 |
Biomarker
|
phenotype |
BEFREE |
We found significant interactions between CAG repeat length and testosterone, indicating that FT was more positively related to ART and NART with a shorter repeat length, and that an inverse association of FT with depressive symptoms and a positive association with self-esteem were stronger in boys with a longer CAG repeat length.
|
20479013 |
2010 |